Nrf2-keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells

Neuroendocrinology

Volumn 97, Issue 3, 2013, Pages 232-241

  Chen, Cheng Sheng ^a,b   Tseng, Yu Ting ^b   Hsu, Ya Yun ^b   Lo, Yi Ching ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

17 estradiol; Akt GSK 3 ; Apoptosis; Homocysteine; Kelch like ECH associated protein 1 nuclear factor erythroid 2 related factor 2; Reactive oxygen species; Superoxide dismutase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 9; CYTOCHROME C; ESTRADIOL; FULVESTRANT; GLYCOGEN SYNTHASE KINASE 3BETA; HOMOCYSTEINE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TRYPAN BLUE; HEME OXYGENASE 1; PROTEIN KINASE B;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOCHONDRION; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; CYTOSOL; CYTOTOXICITY; ENZYME PHOSPHORYLATION; NEUROBLASTOMA CELL LINE; OXIDATIVE STRESS; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMONES; CYTOCHROMES C; DOPAMINERGIC NEURONS; ESTRADIOL; ESTRADIOL ANTAGONISTS; GLYCOGEN SYNTHASE KINASE 3; HOMOCYSTEINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MORPHOLINES; NF-E2-RELATED FACTOR 2; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 84877925368     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000342692     Document Type: Article

References (39)

1. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483.
2. Miller JW: Homocysteine, folate deficiency, and Parkinson's disease. Nutr Rev 2002; 60: 410-413.
3. 12, homocyste-ine, and the MTHFR 677C-1T polymorphism in anxiety and depression: the Horda-la nd Homoc ysteine Study. A rch Gen Psychiatry 2003; 60:618-626.
4. Chen CS, Tsai JC, Tsang HY, Kuo YT, Lin HF, Chiang IC, Devanand DP: Homocysteine levels, MTHFR C677T genotype, and MRI hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 2005; 13: 869-875.
5. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C: Association of plasma total homocysteine levels with sub-clinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain in-farcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008; 65:642-649.
6. Sachdev P: Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004; 226: 25-29.
7. Tang XQ, Shen XT, Huang YE, Ren YK, Chen RQ, Hu B, He JQ, Yin WL, Xu JH, Jiang ZS: Hydrogen sulfide antagonizes homocyste-ine-induced neurotoxicity in PC12 cells. Neurosci Res 2010; 68:241-249.
8. McEwen BS: Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91: 2785-2801.
9. McEwen BS, Akama KT, Spencer-Segal JL, Milner TA, Waters EM: Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms. Behav Neurosci 2012; 126:4-16.
10. Zhao L, Chen Q, Diaz Brinton R: Neuropro-tective and neurotrophic efficacy of phy-toestrogens in cultured hippocampal neurons. Exp Biol Med (Maywood) 2002; 227: 509-519.
11. Park YJ, Jang YM, Kwon YH: Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y cells. J Med Food 2009; 12: 528-535.
12. Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, Hurn PD, McCullough LD: Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab 2011; 31:413-425.
13. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A: Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 21: 1809-1818.
14. Kenchappa RS, Diwakar L, Annepu J, Ravin-dranath V: Estrogen and neuroprotection: Higher constitutive expression of glutare-doxin in female mice offers protection against MPTP-mediated neurodegenera-tion. FASEB J 2004; 18: 1102-1104.
15. Ho PI, Ortiz D, Rogers E, Shea TB: Multiple aspects of homocysteine neurotoxicity: glu-tamate excitotoxicity, kinase hyperactiva-tion and DNA damage. J Neurosci Res 2002; 70:694-702.
16. Tjiattas L, Ortiz DO, Dhivant S, Mitton K, Rogers E, Shea TB: Folate deficiency and ho-mocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accu mulation. Aging Cell 2004; 3: 71-76.
17. Zou CG, Zhao YS, Gao SY, Li SD, Cao XZ, Zhang M, Zhang KQ: Homocysteine promotes proliferation and activation of mi-croglia. Neurobiol Aging 2010; 31: 2069-2079.
18. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Pratico D, Harrison DG, Hsueh WA: Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 2009; 104:e42-e54.
19. Duan W, Zhang R, Guo Y, Jiang Y, Huang Y, Jiang H, Li C: Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. In Vitro Cell Dev Biol Anim 2009; 45: 388-397.
20. 2-re-lated factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signa l 2011; 14: 469-487.
21. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yama-moto M, Talalay P: Direct evidence that sulf-hydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002; 99: 11908-11913.
22. Sies H, Masumoto H: Ebselen as a glutathione peroxidase mimic and as a scavenger of per-oxynitrite. Adv Pharmacol 1997; 38:229-246.
23. Park YJ, Jang Y, Kwon YH: Protective effect of isoflavones against homocysteine-medi-ated neuronal degeneration in SH-SY5Y cells. Amino Acids 2010; 39:785-794.
24. Behl C, Widmann M, Trapp T, Holsboer F: 17-beta estradiol protects neurons from oxi-dat ive stre ss-i nduced cell death in vitro. Biochem Biophys Res Commun 1995; 216:473-482.
25. Behl C, Moosmann B: Antioxidant neuro-protection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med 2002; 33: 182-191.
26. Torres Aleman I: Role of insulin-like grow t h factors in neuronal plasticity and neuropro-tection. Adv Exp Med Biol 2005; 567: 243-258.
27. Garcia-Segura LM, Azcoitia I, DonCarlos LL: Neuroprotection by estradiol. Prog Neu-robiol 2001; 63:29-60.
28. Chen RL, Balami JS, Esiri MM, Chen LK, Bu-chan AM: Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 2010; 6:256-265.
29. Alfieri A, Srivastava S, Siow RC, Modo M, Fraser PA, Mann GE: Targeting the Nrf2-Keap1 antioxidant defence pathway for neu-rovascular protection in stroke. J Physiol 2011; 589:4125-4136.
30. Yan SK, Chang T, Wang H, Wu L, Wang R, Meng QH: Effects of hydrogen sulfide on ho-mocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 485-491.
31. Zou CG, Banerjee R: Homocysteine and re-dox signaling. Antioxid Redox Signal 2005; 7: 547-559.
32. Nguyen T, Nioi P, Pickett CB: The Nrf2-an-tioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009; 284: 13291-13295.
33. Alam J, Cook JL: Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 2003; 9: 2499-2511.
34. Yang C, Zhang X, Fan H, Liu Y: Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009; 1282:133-141.
35. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV, Knapp RR, Zhou X, Cao W: Involvement of insulin/phos-phoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem 2004; 279: 13086-13094.
36. Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F: Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci 2004; 25: 363-373.
37. Ropero AB, Pang Y, Alonso-Magdalena P, Thomas P, Nadal A: Role of ERfS and GPR30 in the endocrine pancreas: a matter of estrogen dose. Steroids 2012; 77: 951-958.
38. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20: 6920-6926.
39. Nilsen J, Brinton RD: Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004; 3:297-313.